# Delivery Order #15B30627F00000038

McKesson Reyataz Delivery Order Under VA Pharmaceutical Prime Vendor Contract

**Buyer:** Federal Prison System / Bureau of Prisons

**Award Amount:** $1,536.70
**Ceiling:** $1,536.70

**Awarded:** November 18, 2026
**Period of Performance:** Nov 18, 2026 - Dec 31, 2026

**Identifier:** 15B30627F00000038
**NAICS:** 325412

This delivery order procures regular-strength Reyataz 300 mg capsules through the Department of Veterans Affairs’ Pharmaceutical Prime Vendor Contract, a long-term indefinite-delivery vehicle. McKesson Corporation, a pharmaceutical distributor, supplies the medication for VA healthcare needs. The order supports continuity of access to prescribed treatment for veterans and is part of the broader pharmaceutical supply arrangement. The parent contract was awarded following full and open competition; the provided order data does not identify a separate competition or sole-source justification. Its performance period runs from November 18 through December 31, 2026. No acquisition program, subcontractor, prior related order, or original solicitation details are provided for this delivery order.

### Description

REGULAR MED.  REYATAZ CAP.300MG

[View original record](https://www.usaspending.gov/award/CONT_AWD_15B30627F00000038_1540_36W79720D0001_3600)
